| Literature DB >> 35425772 |
Edilson Coelho Sampaio1,2, Cintia Yolette Urbano Pauxis Aben-Athar1,2, Denise da Silva Pinto1,3, Antonio Carlos Rosário Vallinoto2, Izaura Maria Vieira Cayres Vallinoto1,2.
Abstract
Introduction: Human T-lymphotropic virus 1 (HTLV-1)-associated myelopathy (HAM) restricts activities of daily living (ADLs), affecting health and quality of life. Occupational therapy is used to promote independence during ADL in people living with HTLV (PLHTLV). Objective: To quantify the clinical aspects, levels of functionality, performance in ADLs and occupational roles of PLHTLV and propose an occupational therapeutic intervention. Method: A cross-sectional, descriptive, observational study was designed with 40 PLHTLV monitored at two referral laboratories of the Federal University of Pará. The Evandro Chagas Research Institute Neurological Disability Scale (EIPEC-2), the Barthel Index and the Occupational Roles Identification List were applied. The G test and Fisher's exact test (to identify associations between qualitative variables), the Mann-Whitney test (to identify associations between quantitative variables) and Pearson correlation analysis (to identify associations between the total Barthel Index and EIPEC-2 scores) were performed with Microsoft Excel and BioEstat 5.0, and the significance level was set at p ≤ 0.05.Entities:
Keywords: HAM; HTLV-1; activity of daily living; intervention plan; occupational roles; occupational therapy; public health policy
Year: 2022 PMID: 35425772 PMCID: PMC9001934 DOI: 10.3389/fmed.2022.859889
Source DB: PubMed Journal: Front Med (Lausanne) ISSN: 2296-858X
Distribution of patients infected by HTLV-1 based on the clinical and functional characteristics of the Evandro Chagas Research Institute Neurological Disability Scale (EIPEC-2) by group of patients.
| Evaluation | Asymptomatic ( | Symptomatic ( | |
|
| |||
| Median (ID) | Median (ID) | ||
| EIPEC-2 | 2.0 (4.0) | 13.0 (15.0) | 0.0002 |
Mann–Whitney test.
ID, interquartile deviation.
Distribution of patients infected by HTLV-1 based on clinical and functional characteristics and clinical classification.
| Variable | Asymptomatic ( | Symptomatic ( | |||
|
| % |
| % | ||
|
| |||||
|
| |||||
| 0. Normal | 26 | 96.3 | 03 | 23.1 | 0.0030 |
| 1. Abnormal, but walks independently | 01 | 3.7 | 05 | 38.5 | |
| 3. Abnormal and depends on permanent unilateral support | 00 | 0.0 | 02 | 15.4 | |
| 6. Abnormal, permanent bilateral support, and occasional use of WC | 00 | 0.0 | 01 | 7.7 | |
| 9. Permanent use of WC, standing up with help, standing with support | 00 | 0.0 | 01 | 7.7 | |
| 1. Permanent use of WC, unable to stand up | 00 | 0.0 | 01 | 7.7 | |
|
| |||||
| Runs | 25 | 92.6 | 04 | 30.8 | 0.0001 |
| Unable to run | 02 | 7.4 | 09 | 69.2 | |
|
| |||||
| Climbs up stairs | 26 | 96.3 | 03 | 23.1 | 0.0001 |
| Climbs up stairs only with handrail | 01 | 3.7 | 06 | 46.2 | |
| Unable to climb up stairs | 00 | 0.0 | 04 | 30.8 | |
|
| |||||
| Jumps with 1 or 2 feet | 25 | 92.6 | 04 | 30.8 | 0.0020 |
| Jumps only with both feet | 00 | 0.0 | 01 | 7.7 | |
| Unable to jump | 02 | 7.4 | 08 | 61.5 | |
|
| |||||
| Clonus | 1.0000 | ||||
| Absent | 26 | 96.3 | 06 | 46.2 | |
| Only induced by the examiner | 00 | 0.0 | 00 | 0.0 | |
| Spontaneous | 01 | 3.7 | 07 | 53.8 | |
|
| |||||
| Absent | 25 | 92.6 | 05 | 38.5 | 0.0010 |
| Present | 02 | 7.4 | 08 | 61.5 | |
|
| |||||
| Paresthesia | 0.0001 | ||||
| Absent | 18 | 66.7 | 02 | 15.4 | |
| Present occasionally | 09 | 33.3 | 04 | 30.8 | |
| Present constantly | 00 | 0.0 | 07 | 53.8 | |
| Lumbar pain | 0.0300 | ||||
| Absent | 10 | 37.0 | 02 | 15.4 | |
| Present occasionally | 12 | 44.4 | 03 | 23.1 | |
| Present constantly | 05 | 18.5 | 08 | 61.5 | |
| Lower limb pain | 0.0060 | ||||
| Absent | 14 | 51.9 | 03 | 23.1 | |
| Present occasionally | 12 | 44.4 | 04 | 30.8 | |
| Present constantly | 01 | 3.7 | 06 | 46.2 | |
|
| |||||
|
| |||||
| Total | 22 | 81.5 | 04 | 30.8 | 0.0070 |
| Urgency | 04 | 14.8 | 05 | 38.5 | |
| Incontinence or occasional retention | 01 | 3.7 | 04 | 30.8 | |
|
| |||||
| Normal | 23 | 85.2 | 08 | 61.5 | 0.1000 |
| Constipation | 04 | 14.8 | 05 | 38.5 | |
Distribution of patients based on the total Barthel Index score by group.
| Barthel Index | Asymptomatic ( | Symptomatic ( | |||
|
| % |
| % | ||
| Level of functional independence | 0.0300 | ||||
| Independent | 27 | 100.0 | 10 | 76.9 | |
| Dependent | 00 | 0.0 | 03 | 23.1 | |
Distribution of patients based on the Occupational Roles Identification List score by group.
| Variable | Asymptomatic ( | Symptomatic ( | |||
|
| % |
| % | ||
|
| |||||
|
| |||||
| PAST | 0.0600 | ||||
| Yes | 11 | 40.7 | 1 | 7.7 | |
| No | 16 | 59.3 | 12 | 92.3 | |
| PRESENT | 0.6000 | ||||
| Yes | 02 | 7.4 | 02 | 15.4 | |
| No | 25 | 92.6 | 11 | 84.6 | |
| FUTURE | 0.3000 | ||||
| Yes | 12 | 44.4 | 03 | 23.1 | |
| No | 15 | 55.6 | 10 | 76.9 | |
|
| |||||
| PAST | 0.6000 | ||||
| Yes | 25 | 92.6 | 11 | 84.6 | |
| No | 02 | 7.4 | 02 | 15.4 | |
| PRESENT | 0.0400 | ||||
| Yes | 16 | 59.3 | 03 | 23.1 | |
| No | 11 | 40.7 | 10 | 76.9 | |
| FUTURE | 0.7000 | ||||
| Yes | 23 | 85.2 | 10 | 76.9 | |
| No | 04 | 14.8 | 03 | 23.1 | |
|
| |||||
| PAST | 1.0000 | ||||
| Yes | 10 | 37.0 | 05 | 38.5 | |
| No | 17 | 63.0 | 08 | 61.5 | |
| PRESENT | 0.3000 | ||||
| Yes | 02 | 7.4 | 02 | 15.4 | |
| No | 25 | 92.6 | 11 | 84.6 | |
| FUTURE | 0.1000 | ||||
| Yes | 05 | 18.5 | 06 | 46.2 | |
| No | 22 | 81.5 | 07 | 53.8 | |
|
| |||||
|
| |||||
| PAST | 0.3000 | ||||
| Yes | 23 | 85.2 | 13 | 100.0 | |
| No | 04 | 14.8 | 00 | ||
| PRESENT | 0.1000 | ||||
| Yes | 20 | 74.1 | 06 | 46.2 | |
| No | 07 | 25.9 | 07 | 53.8 | |
| FUTURE | 0.4000 | ||||
| Yes | 23 | 85.2 | 09 | 69.2 | |
| No | 04 | 14.8 | 04 | 30.8 | |
|
| |||||
| PAST | 0.2000 | ||||
| Yes | 26 | 96.3 | 11 | 84.6 | |
| No | 01 | 3.7 | 02 | 15.4 | |
| PRESENT | 0.0006 | ||||
| Yes | 26 | 96.3 | 06 | 46.2 | |
| No | 01 | 3.7 | 07 | 53.8 | |
| FUTURE | 0.0080 | ||||
| Yes | 27 | 100.0 | 09 | 69.2 | |
| No | 00 | 0.0 | 04 | 30.8 | |
|
| |||||
|
| |||||
| PAST | 0.7000 | ||||
| Yes | 20 | 74.1 | 11 | 84.6 | |
| No | 07 | 25.9 | 02 | 15.4 | |
| PRESENT | 0.0100 | ||||
| Yes | 13 | 48.1 | 01 | 7.7 | |
| No | 14 | 51.9 | 12 | 92.3 | |
| FUTURE | 0.0800 | ||||
| Yes | 24 | 88.9 | 08 | 61.5 | |
| No | 03 | 11.1 | 05 | 38.5 | |
|
| |||||
| PAST | 0.6000 | ||||
| Yes | 22 | 81.5 | 12 | 92.3 | |
| No | 05 | 18.5 | 01 | 7.7 | |
| PRESENT | 0.0020 | ||||
| Yes | 21 | 77.8 | 03 | 23.1 | |
| No | 06 | 22.2 | 10 | 76.9 | |
| FUTURE | 0.0900 | ||||
| Yes | 26 | 96.3 | 10 | 76.9 | |
| No | 01 | 3.7 | 03 | 23.1 | |
|
| |||||
|
| |||||
| PAST | 0.7000 | ||||
| Yes | 14 | 51.9 | 08 | 61.5 | |
| No | 13 | 48.1 | 05 | 38.5 | |
| PRESENT | 1.0000 | ||||
| Yes | 16 | 59.3 | 07 | 53.8 | |
| No | 11 | 40.7 | 06 | 46.2 | |
| FUTURE | 0.3000 | ||||
| Yes | 25 | 92.6 | 10 | 76.9 | |
| No | 02 | 7.4 | 03 | 23.1 | |
|
| |||||
| PAST | 0.1000 | ||||
| Yes | 18 | 66.7 | 12 | 92.3 | |
| No | 09 | 33.3 | 01 | 7.7 | |
| PRESENT | 0.7000 | ||||
| Yes | 09 | 33.3 | 03 | 23.1 | |
| No | 18 | 66.7 | 10 | 76.9 | |
| FUTURE | 0.0900 | ||||
| Yes | 26 | 96.3 | 10 | 76.9 | |
| No | 01 | 3.7 | 03 | 23.1 | |
|
| |||||
| PAST | 0.5000 | ||||
| Yes | 02 | 7.4 | 00 | 0.0 | |
| No | 25 | 92.6 | 13 | 100.0 | |
| PRESENT | 0.1000 | ||||
| Yes | 02 | 7.4 | 01 | 7.7 | |
| No | 25 | 92.6 | 12 | 92.3 | |
| FUTURE | 0.1000 | ||||
| Yes | 02 | 7.4 | 01 | 7.7 | |
| No | 25 | 92.6 | 12 | 92.3 | |
FIGURE 1Correlation of the Evandro Chagas Research Institute Neurological Disability Scale (EIPEC-2) with the Barthel Index, Belém, Pará.
FIGURE 2Flowchart of the proposal for an occupational therapy intervention plan for people living with HTLV-1. ADLs, activities of daily living; IADLs, instrumental activities of daily living.